ESC 365 - Effect of beta blocker therapy following myocardial infarction in optimally treated patients in the reperfusion era - a Danish, nationwide, and registry-based cohort study

ESC Premium Access

Effect of beta blocker therapy following myocardial infarction in optimally treated patients in the reperfusion era - a Danish, nationwide, and registry-based cohort study

Session: Young Investigator Award Session Population Sciences

Topic: Beta-Blockers

Speaker: Mr A. Holt (Copenhagen, DK)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Mr Anders Holt

Copenhagen University Hospital, Copenhagen (Denmark)

0 follower

3 more presentations in this session

Regular exercise after a diagnosis of atrial fibrillation and lower risks of cardiovascular disease: a nationwide population-based study

Speaker: Doctor H. Ahn (Seoul, KR)

Predicted lifetime therapy benefit guided treatment effectively reduces residual cardiovascular risk in patients with symptomatic atherosclerotic disease

Speaker: Mr S. Hageman (Utrecht, NL)

The association of artificial intelligence-enabled electrocardiogram-derived age (physiologic age) with atherosclerotic cardiovascular events in the community

Speaker: Doctor J. Medina-Inojosa (Rochester, US)

Access the full session

Young Investigator Award Session Population Sciences

Speakers: Mr A. Holt, Doctor H. Ahn, Mr S. Hageman, Doctor J. Medina-Inojosa

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources